Tag: ReNetX Bio
ReNetX Bio Receives Fast Track Designation From U.S. FDA
Potential First-in-Class Therapy for Chronic Spinal Cord Injury
NEW HAVEN, Conn., Jan. 08, 2020 (GLOBE NEWSWIRE) -- ReNetX Bio announced today that the U.S. Food and Drug...
Drug aims to help treat spinal cord injuries
Researchers at ReNetX Bio are hoping a new name, the potential for a new influx of cash on the horizon and a new chief...
